First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): Identification of novel RAMBA scaffolds

被引:16
作者
Purushottamachar, Puranik [1 ,3 ]
Patel, Jyoti B. [3 ]
Gediya, Lalji K. [1 ,3 ]
Clement, Omoshile O. [4 ]
Njar, Vincent C. O. [1 ,2 ,3 ]
机构
[1] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA
[4] Accelrys Inc, San Diego, CA 92121 USA
基金
美国国家卫生研究院;
关键词
Common feature-based pharmacophore hypotheses; HipHop; Retinoic acid metabolism blocking agents (RAMBAs); Docking; Quantitative structure-activity relationships; Anti-cancer agents; PROSTATE-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; HUMAN BREAST; OXIDATIVE CATABOLISM; 4-HYDROXYLASE CYP26; CYTOCHROME-P450; GROWTH; CARCINOGENESIS; ENZYMES;
D O I
10.1016/j.ejmech.2011.11.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The first three-dimensional (3D) pharmacophore model was developed for potent retinoidal retinoic acid metabolism blocking agents (RAMBAs) with IC50 values ranging from 0.0009 to 5.84 nM. The seven common chemical features in these RAMBAs as deduced by the Catalyst/HipHop program include five hydrophobic groups (hydrophobes), and two hydrogen bond acceptors. Using the pharmacophore model as a 3D search query against NCI and Maybridge conformational Catalyst formatted databases; we retrieved several compounds with different structures (scaffolds) as hits. Twenty-one retrieved hits were tested for RAMBA activity at 100 nM concentration. The most potent of these compounds, NCI10308597 and HT501914 showed inhibitory potencies less (54.7% and 53.2%, respectively, at 100 nM) than those of our best previously reported RAMBAs VN/12-1 and VN/14-1 (90% and 86%, respectively, at 100 nM). Docking studies using a CYP26A1 homology model revealed that our most potent RAMBAs showed similar binding to the one observed for a series of RAMBAs reported previously by others. Our data shows the potential of our pharmacophore model in identifying structurally diverse and potent RAMBAs. Further refinement of the model and searches of other robust databases is currently in progress with a view to identifying and optimizing new leads. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:412 / 423
页数:12
相关论文
共 65 条
[1]   Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor γ and retinoid X receptor α [J].
Abu-Abed, SS ;
Beckett, BR ;
Chiba, H ;
Chithalen, JV ;
Jones, G ;
Metzger, D ;
Chambon, P ;
Petkovich, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2409-2415
[2]  
[Anonymous], CAT REL VERS 4 10
[3]   Identification of common functional configurations among molecules [J].
Barnum, D ;
Greene, J ;
Smellie, A ;
Sprague, P .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :563-571
[4]  
BHAT PV, 1989, CANCER RES, V49, P139
[5]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[6]   Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development [J].
Bruno, Robert D. ;
Njar, Vincent C. O. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) :5047-5060
[7]   Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy [J].
Clement, OO ;
Freeman, CM ;
Hartmann, RW ;
Handratta, VD ;
Vasaitis, TS ;
Brodie, AMH ;
Njar, VCO .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) :2345-2351
[8]  
Clement OO, 2000, IUL BIOTECH, V2, P69
[9]  
Edger E.S., 2000, J MOL GRAPH MODEL, V18, P343
[10]   Synthesis of liazal™, a retinoic acid metabolism blocking agent (RAMBA) with potential clinical applications in oncology and dermatology [J].
Freyne, E ;
Raeymaekers, A ;
Venet, M ;
Sanz, G ;
Wouters, W ;
De Coster, R ;
Van Wauwe, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (03) :267-272